Please login to the form below

Not currently logged in
Email:
Password:

CDM Group re-brands non-US businesses

Develops platform for agencies to focus on growth

CDM Group re-brands non-US businessesCDM Group has carried out a rebrand of its businesses outside the US by creating a platform to focus on growth.

The development affects the healthcare advertising group's operations in Paris, Munich, Barcelona, Milan, Montreal and Sao Paulo, each of which will operate under the “Come Grow With Us” platform. 

Jon Lee, managing director of CDM London, described the new banner as a “natural platform” for the agency's clients.

“Growth is ultimately what our clients seek for their brands – whether in terms of sales, revenue or market share,” he said. 

The exclusion of the US operation from the re-branding was because CDM is sufficiently well-known there, CDM Group managing partner, director of global operations Eric Berkeley told PMLiVE. 

“We realised that CDM was not as well known in other countries, and we needed a banner that would differentiate us from the competition,” he said. 

The re-branding has involved redesigning both the website and the offices.
“Everything that the client sees will convey a sense of growth,” said Berkeley. 

The CDM Group was founded in 1984, and since 1987 has been a wholly owned company within the Omnicom Group.  It is currently looking at entering the Chinese market, Berkeley told PMLiVE.

Article by
Tara Craig

19th September 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics